470 related articles for article (PubMed ID: 21194593)
1. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
Crank CW; Scheetz MH; Brielmaier B; Rose WE; Patel GP; Ritchie DJ; Segreti J
Clin Ther; 2010 Sep; 32(10):1713-9. PubMed ID: 21194593
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
Mave V; Garcia-Diaz J; Islam T; Hasbun R
J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543
[TBL] [Abstract][Full Text] [Related]
3. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy.
Le J; Bookstaver PB; Rudisill CN; Hashem MG; Iqbal R; James CL; Sakoulas G
Ann Pharmacother; 2010 Dec; 44(12):2001-6. PubMed ID: 21119097
[TBL] [Abstract][Full Text] [Related]
4. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.
Erlandson KM; Sun J; Iwen PC; Rupp ME
Clin Infect Dis; 2008 Jan; 46(1):30-6. PubMed ID: 18171210
[TBL] [Abstract][Full Text] [Related]
5. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC
J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
King EA; McCoy D; Desai S; Nyirenda T; Bicking K
J Antimicrob Chemother; 2011 Sep; 66(9):2112-8. PubMed ID: 21697178
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin-resistant enterococcal bacteremia pharmacotherapy.
Patel R; Gallagher JC
Ann Pharmacother; 2015 Jan; 49(1):69-85. PubMed ID: 25352037
[TBL] [Abstract][Full Text] [Related]
8. Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review.
Shukla BS; Gauthier TP; Correa R; Smith L; Abbo L
Int J Clin Pharm; 2013 Oct; 35(5):697-703. PubMed ID: 23893061
[TBL] [Abstract][Full Text] [Related]
9. Intraventricular daptomycin and intravenous linezolid for the treatment of external ventricular-drain-associated ventriculitis due to vancomycin-resistant Enterococcus faecium.
Mueller SW; Kiser TH; Anderson TA; Neumann RT
Ann Pharmacother; 2012 Dec; 46(12):e35. PubMed ID: 23232018
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.
Babcock HM; Ritchie DJ; Christiansen E; Starlin R; Little R; Stanley S
Clin Infect Dis; 2001 May; 32(9):1373-5. PubMed ID: 11303275
[TBL] [Abstract][Full Text] [Related]
11. The use of linezolid in the treatment of paediatric patients with infections caused by enterococci including strains resistant to vancomycin.
Deville JG; Goldfarb J; Kaplan SL; Equils O; Huang DB; Ang JY; Salazar JC
J Antimicrob Chemother; 2010 Oct; 65(10):2267-70. PubMed ID: 20705627
[No Abstract] [Full Text] [Related]
12. Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients.
Gallagher JC; Perez ME; Marino EA; LoCastro LG; Abrardo LA; MacDougall C
Pharmacotherapy; 2009 Jul; 29(7):792-9. PubMed ID: 19558253
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of low-dose daptomycin in the treatment of vancomycin-resistant enterococcal urinary tract infections.
Fisher L; North D
Int J Antimicrob Agents; 2009 May; 33(5):493-4. PubMed ID: 19153034
[No Abstract] [Full Text] [Related]
14. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients.
Britt NS; Potter EM; Patel N; Steed ME
Clin Infect Dis; 2015 Sep; 61(6):871-8. PubMed ID: 26063715
[TBL] [Abstract][Full Text] [Related]
16. Optimizing therapy for vancomycin-resistant enterococci (VRE).
Linden PK
Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacoeconomic assessment of daptomycin as first-line therapy for bacteraemia and complicated skin and skin structure infections caused by gram-positive pathogens in Spain].
Grau S; Rebollo P; Cuervo J; Gil-Parrado S
Rev Esp Quimioter; 2011 Sep; 24(3):154-63. PubMed ID: 21947099
[TBL] [Abstract][Full Text] [Related]
18. Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis.
Chuang YC; Wang JT; Lin HY; Chang SC
BMC Infect Dis; 2014 Dec; 14():687. PubMed ID: 25495779
[TBL] [Abstract][Full Text] [Related]
19. Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature.
Jasovich A; Ganaha MC; Ebi C; García RD; Blanco MA; Lopardo H
Rev Argent Microbiol; 2008; 40(4):204-7. PubMed ID: 19213241
[TBL] [Abstract][Full Text] [Related]
20. [Our experience with linesolid usage in newborn children].
Atanasova V; Slavkova N; Rosmanova R
Akush Ginekol (Sofiia); 2007; 46 Suppl 1():60-2. PubMed ID: 18173016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]